Moderna (MRNA) had the highest return between 2019 and 2022 by a large-cap US stock, returning 1,103.1%.
| ASSET | YEARS | % RETURN |
|---|---|---|
Moderna (MRNA) | 2019-2022 | 1,103.08% |
Lattice Semiconductor (LSCC) | 2019-2022 | 845.77% |
BioNTech SE (BNTX) | 2019-2022 | 822.48% |
Sitime (SITM) | 2019-2022 | 681.69% |
Freedom (FRHC) | 2019-2022 | 623.23% |
GameStop (GME) | 2019-2022 | 513.21% |
Dillard's (DDS) | 2019-2022 | 513.1% |
Tesla (TSLA) | 2019-2022 | 503.63% |
Super Micro Computer (SMCI) | 2019-2022 | 495.36% |
Quanta Services (PWR) | 2019-2022 | 387.42% |
Texas Pacific Land (TPL) | 2019-2022 | 374.86% |
Sea (SE) | 2019-2022 | 367.9% |
KLA (KLAC) | 2019-2022 | 360.51% |
Ares Management (ARES) | 2019-2022 | 355.88% |
Immunitybio (IBRX) | 2019-2022 | 352.68% |
NVIDIA (NVDA) | 2019-2022 | 350.76% |
Dick’s Sporting Goods (DKS) | 2019-2022 | 349.92% |
United Microelectronics (UMC) | 2019-2022 | 348.52% |
MACOM Technology Solutions (MTSI) | 2019-2022 | 344.46% |
Medpace (MEDP) | 2019-2022 | 307.38% |
Freeport-McMoran Copper & Gold (FCX) | 2019-2022 | 297.35% |
Halozyme Therapeutics (HALO) | 2019-2022 | 294.86% |
argenx NV ADR (ARGX) | 2019-2022 | 288.15% |
Synopsys (SNPS) | 2019-2022 | 287.63% |
DexCom (DXCM) | 2019-2022 | 287.11% |
Large-cap stocks are treated as having a market cap of $10B+.